Ladenburg Thalmann downgraded its rating on Response Genetics (NASDAQ:
RGDX) from Buy to Neutral. At the same time, the rating agency removed its price target on the company's stock. Its previous price target was $3.50. On Monday, RGDX closed the day at $2.49.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
